Evaluation reports
FR
BMGIC - Biothérapies des maladies génétiques, inflamatoires et du cancer
Type: Research unit evaluation report
Evaluation campaign: 2014-2015 (group A)
- Published on: 20/08/2015
Institution(s) concerned:
Université de Bordeaux
, Institut national de la santé et de la recherche médicale - INSERM
Disciplinary research field: Life and Earth Sciences (SVE) ; SVE5 Physiology, Physiopathology, Cardiology, Pharmacology, Enocrinology, Cancer, Medical Technologies
Scientific field(s): 5 - Biologie, medecine et santé
ERC panel(s): LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS6 Immunity and infection: immunobiology, aetiology of immune disorders, microbiology, virology, parasitology, global and other infectious diseases, population dynamics of infectious diseases, veterinary medicine ; LS9 Applied life sciences and biotechnology: agricultural, animal, fishery, forestry and food sciences
Name of unit teams: Biothérapies-IPSC ; Dermatologie ; Hématopoïèse leucémique et cibles ; ATIP-AVENIR immuno- dermatologie ; miRCaDe
Keywords: Cellules souches ; IPSC ; maladies rares ; dermatologie ; hématologie ; cancer ; xeroderma pigmentosum ; vitiligo ; immunodermatologie ; leucémies ; porphyries ; hyperoxalurie ; hepatoblastome